Femoral vein-to-artery diameter ratio to predict fluid responsiveness
Official title: Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio: A Prospective Observational Study
Run by Istanbul University - Cerrahpasa · NCT07546656 · Data updated 2026-11-12
This project will test whether a bedside ultrasound measurement of the femoral vein-to-artery diameter ratio can tell if mechanically ventilated ICU patients with acute circulatory failure or shock will increase their cardiac output after a 500 mL fluid bolus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul, Istanbul) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07546656 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults in the study ICU on invasive mechanical ventilation with acute circulatory failure or shock who already have PiCCO monitoring and a planned clinical fluid challenge are the ideal candidates.
✕Probably not a fit
Patients who are not mechanically ventilated, lack PiCCO monitoring, have contraindications to femoral ultrasound (for example groin injury) or cannot undergo a fluid challenge are unlikely to benefit from these results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center observational study enrolling mechanically ventilated adult ICU patients with acute circulatory failure or shock who already have PiCCO monitoring and a clinician-planned fluid challenge. Baseline cardiac index will be recorded with PiCCO and femoral vein and artery diameters measured by bedside ultrasound, with each ultrasound repeated at least three times and averaged. A 500 mL balanced crystalloid will be given over 10 minutes and cardiac index remeasured, with fluid responsiveness defined as a >10% increase in cardiac index. The diagnostic performance of the femoral vein-to-artery diameter ratio will be compared to the PiCCO-derived change in cardiac index, and no additional invasive procedures will be performed for research purposes.
Why it matters
Potential benefit: If successful, this simple ultrasound ratio could provide a quick bedside tool to help clinicians choose who will benefit from fluids and avoid unnecessary fluid loading.
How similar studies have gone: Other ultrasound-based markers such as IVC or venous size indices have shown mixed accuracy, and the femoral vein-to-artery ratio is a relatively novel bedside parameter with limited prior validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 18 years or older * Admission to the intensive care unit where the study is being conducted * Receiving invasive mechanical ventilation * Clinical indication for a fluid challenge due to acute circulatory failure or shock, as determined by the responsible intensive care physician * PiCCO monitoring already in place as part of routine clinical care * Clinical conditions allowing collection of pre- and post-fluid challenge cardiac index and ultrasonographic measurements * Technical feasibility of femoral vein and femoral artery diameter measurements by ultrasonography Exclusion Criteria: * Age younger than 18 years * Failure to obtain written informed consent from the patient or legally authorized representative before enrollment * Absence of PiCCO monitoring as part of routine clinical care or no clinical plan for fluid challenge * Inability to complete pre- and post-fluid challenge measurements (e.g., early death, urgent surgery, transfer) * Local conditions preventing reliable femoral ultrasonographic assessment, including open wound, infection, dressing, major anatomic obstacle, poor image quality, known femoral vein thrombosis, or severe vascular pathology on the relevant side * Conditions likely to significantly impair the reliability of thermodilution measurements (e.g., severe tricuspid regurgitation or significant intracardiac shunt) * Major treatment changes during the fluid challenge that preclude comparable measurements (e.g., major vasopressor dose change, major ventilator setting change, new arrhythmia) * Missing or inadequate data judged by the investigators to compromise data integrity, including absence of measurements required for the primary outcome
Where it's running
-
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: mert katılmış
- Email: mertkatilmis97@gmail.com
- Phone: +905346430560
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized IV fluid care for sepsis in the emergency department
This study will test whether giving IV fluids based on each adult's heart response helps people with suspected sepsis in the emergency department recover more safely than standard fluid care.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Argos system to track cardiac output changes in critically ill patients
This study tests whether the Argos monitor can reliably track how cardiac output changes after fluid administration or norepinephrine adjustments in critically ill adults already monitored with transpulmonary thermodilution.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Right ventricular–arterial coupling during fluid loading in ICU patients
This study tests how the right ventricle handles fluid changes in critically ill adults to see how it affects blood flow and congestion.
-
Fluid balance guided by mVExUS in ICU patients on CRRT with acute kidney injury
This trial tests whether using modified venous excess ultrasound (mVExUS) to guide fluid removal in ICU patients on CRRT with AKI can achieve a better fluid balance in the first 72 hours compared with standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.